Home/Filings/4/0001104659-22-063025
4//SEC Filing

DST Capital LLC 4

Accession 0001104659-22-063025

CIK 0001563665other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:47 PM ET

Size

8.6 KB

Accession

0001104659-22-063025

Insider Transaction Report

Form 4
Period: 2022-05-12
Transactions
  • Purchase

    Warrants (right to buy)

    2022-05-12+4,1394,139 total
    Exercise: $8.88From: 2022-05-12Exp: 2027-05-12Common Stock (4,139 underlying)
  • Purchase

    Common Stock

    2022-05-12$5.92/sh+8,277$49,0003,658,277 total
Holdings
  • Common Stock

    (indirect: Owned by sole member of reporting person)
    30,722
Footnotes (1)
  • [F1]On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001727656

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:47 PM ET
Size
8.6 KB